EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of oral immunotherapy on diversity of gut microbiota in food‐allergic children

Thanina Bouabid, Bénédicte L Tremblay, Marie-Ève Lavoie, Anne-Marie Boucher-Lafleur, Frédérique Gagnon-Brassard, Philippe Bégin, Sarah Lavoie, Cloé Rochefort-Beaudoin, Claudia Nuncio-Naud, Guy Parizeault, Charles Morin, Catherine Girard und 2 weitere

Pediatric Allergy and Immunology · 2025

DOI: 10.1111/pai.70156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2025. Verfasst von Thanina Bouabid und 13 weiteren Autor:innen. Beteiligte Einrichtung: Département des sciences fondamentales, Université du Québec à Chicoutimi, Saguenay, Quebec, Canada. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Food Hypersensitivity, Desensitization, Immunologic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondation de ma vie, Canada Research Chairs, Fondation de l'UQAC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Food allergies (FAs) are an increasing public health concern, particularly in children. Oral immunotherapy (OIT) is an emerging treatment strategy under clinical investigation for desensitization of children with FA to food allergens. Dysbiosis of the gut microbiota has been implicated in FAs, and various factors influence its composition; however, the impact of OIT on the gut microbiota remains largely unexplored.

Objective

This study aimed to identify the changes in diversity of the gut microbiota following OIT in children with FA.

Methods

Thirty children with FA (mean age 3.93 years, age range 2.00–14.00) undergoing oral immunotherapy targeting legumes (lentils, peanuts, peas), tree nuts (cashews, hazelnuts, pistachios), animal products (milk, egg), and fish and shellfish (salmon, shrimp), as well as seven non‐allergic controls (mean age 2.65 years, age range 0.25–5.00) participated in this study. Fecal samples were collected before and after OIT from children with FA, and once from controls. The gut microbiota was profiled using 16S rRNA sequencing, followed by diversity and differential abundance analyses. Alpha and beta diversities were compared, and differential abundance was assessed.

Results

Beta diversity analysis revealed small but significant differences in microbial composition between children with FA before and after OIT, and between controls and children with FA before OIT. Differential abundance analysis showed that OIT induced a reversion of the abundance levels of Bacteroidota and Verrucomicrobiota toward those observed in controls.

Conclusion

To our knowledge, this is the first study to investigate the impact of OIT on the gut microbiota in children with different FAs for identifying potential microbial biomarkers and convincingly demonstrated their interrelation. These findings may help improve and personalize FA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeFood HypersensitivityDesensitization, ImmunologicHumansFemaleChildMaleChild, PreschoolAdolescentAdministration, OralAllergensRNA, Ribosomal, 16SDysbiosisFecesInfant

Stichwörter der Autor:innen

bacteroidotachildrenfood allergygut microbiotaoral immunotherapyverrucomicrobiota

Substanzen

AllergensRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Département des sciences fondamentales, Université du Québec à Chicoutimi, Saguenay, Quebec, Canada.
  • Centre intersectoriel en santé durable, Université du Québec à Chicoutimi, Saguenay, Quebec, Canada.
  • Division d'immunologie clinique, de rhumatologie et d'allergie, Département de pédiatrie, Centre hospitalier universitaire Sainte-Justine, Montréal, Quebec, Canada.
  • Zéro allergie research clinic of the Université du Québec à Chicoutimi and the Centre intégré universitaire de santé et de services sociaux du Saguenay-Lac-Saint-Jean, Saguenay, Quebec, Canada.

ORCID-Profile: Catherine Laprise

Förderung

  • Fondation de ma vie
  • Canada Research Chairs
  • Fondation de l'UQAC

Zitieren

APA

Bouabid, T., Tremblay, B. L., Lavoie, M. È., Boucher-Lafleur, A. M., Gagnon-Brassard, F., Bégin, P., Lavoie, S., Rochefort-Beaudoin, C., Nuncio-Naud, C., Parizeault, G., Morin, C., Girard, C., Madore, A. M., & Laprise, C. (2025). Impact of oral immunotherapy on diversity of gut microbiota in food‐allergic children. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.70156

Vancouver

Bouabid T, Tremblay BL, Lavoie MÈ, Boucher-Lafleur AM, Gagnon-Brassard F, Bégin P, et al. Impact of oral immunotherapy on diversity of gut microbiota in food‐allergic children. Pediatric Allergy and Immunology. 2025. doi:10.1111/pai.70156

BibTeX
@article{Bouabid2025,
  author = {Bouabid, Thanina and Tremblay, Bénédicte L and Lavoie, Marie-Ève and Boucher-Lafleur, Anne-Marie and Gagnon-Brassard, Frédérique and Bégin, Philippe and Lavoie, Sarah and Rochefort-Beaudoin, Cloé and Nuncio-Naud, Claudia and Parizeault, Guy and Morin, Charles and Girard, Catherine and Madore, Anne-Marie and Laprise, Catherine},
  title = {Impact of oral immunotherapy on diversity of gut microbiota in food‐allergic children},
  journal = {Pediatric Allergy and Immunology},
  year = {2025},
  doi = {10.1111/pai.70156}
}
Kostenlos starten →